Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

Science
H IshiiG L King

Abstract

The vascular complications of diabetes mellitus have been correlated with enhanced activation of protein kinase C (PKC). LY333531, a specific inhibitor of the beta isoform of PKC, was synthesized and was shown to be a competitive reversible inhibitor of PKC beta 1 and beta 2, with a half-maximal inhibitory constant of approximately 5 nM; this value was one-fiftieth of that for other PKC isoenzymes and one-thousandth of that for non-PKC kinases. When administered orally, LY333531 ameliorated the glomerular filtration rate, albumin excretion rate, and retinal circulation in diabetic rats in a dose-responsive manner, in parallel with its inhibition of PKC activities.

References

Feb 14, 1990·Biochemical and Biophysical Research Communications·I YasudaY Nishizuka
May 1, 1989·The Journal of Clinical Investigation·P A Craven, F R DeRubertis
Jul 1, 1989·The Biochemical Journal·F E MitchellP J Parker
May 1, 1988·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M P O'DonnellW F Keane
Mar 13, 1986·Biochemical and Biophysical Research Communications·T TamaokiF Tomita
Feb 1, 1987·Kidney International·C E Mogensen
Jul 31, 1984·Biochemical and Biophysical Research Communications·H RasmussenA Scriabine
Feb 9, 1984·The New England Journal of Medicine·C E Mogensen
Jul 12, 1984·The New England Journal of Medicine·C E Mogensen, C K Christensen
Sep 1, 1993·Kidney International·M HanedaY Shigeta
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J ZhangR W Bond
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
May 1, 1945·The Journal of Clinical Investigation·H W SmithM Graber

❮ Previous
Next ❯

Citations

Feb 24, 2000·The Journal of Pathology·H Li, U Förstermann
Nov 25, 1998·Journal of Cellular Biochemistry·K KamalB E Sumpio
Dec 13, 2000·Diabetes/metabolism Research and Reviews·S ChakrabartiS Chen
Jul 12, 2002·Microscopy Research and Technique·Ronald G Tilton
Jul 26, 2005·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Kazuhiro IrieHajime Ohigashi
Jan 7, 2000·Biochemical and Biophysical Research Communications·N SheibaniW A Frazier
Dec 14, 2004·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·G E Lang
Jul 17, 2004·Histochemistry and Cell Biology·George L King, Mary R Loeken
Oct 25, 2008·Cardiovascular Drugs and Therapy·Nehal N MehtaMuredach P Reilly
Feb 27, 2010·Reviews in Endocrine & Metabolic Disorders·Corey E TabitJoseph A Vita
Mar 16, 2007·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Lijun YaoZhonghua Zhu
Jul 22, 2004·Current Diabetes Reports·Seok Man SonKathy K Griendling
Jul 18, 2008·Current Diabetes Reports·Thomas W Gardner, David A Antonetti
Sep 3, 2004·Current Hypertension Reports·Markus LassilaKarin Jandeleit-Dahm
Mar 8, 2005·Current Hypertension Reports·Volker VallonScott Thomson
Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Jan J BlomWilliam D Eldred
Apr 28, 2004·The International Journal of Biochemistry & Cell Biology·Nicole S Harhaj, David A Antonetti
Jun 15, 2004·Medical Hypotheses·S Yamagishi, M Takeuchi
Oct 25, 2003·Progress in Retinal and Eye Research·Arup Das, Paul G McGuire
May 10, 2005·Journal of Molecular and Cellular Cardiology·Andrew J BoyleRichard E Gilbert
May 7, 2002·American Journal of Ophthalmology·Robert N Frank
Jul 2, 2003·American Journal of Ophthalmology·Lloyd M Aiello
Sep 5, 2002·Biochemical and Biophysical Research Communications·Motohide IsonoFuad N Ziyadeh
Jun 8, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·R Lehmann, E D Schleicher
Sep 5, 2003·European Journal of Pharmacology·Matthew R NangleNorman E Cameron
Jan 5, 2000·European Journal of Pharmacology·G P SamokhinR A Henriksen
Jan 1, 2003·Survey of Ophthalmology·Donald S Fong
Jan 1, 2003·Survey of Ophthalmology·Lloyd Paul Aiello
Nov 29, 1996·Mechanisms of Ageing and Development·W MlekuschG Reibnegger
Aug 24, 1999·Pharmacology & Therapeutics·P J Parker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.